Semin Neurol 2021; 41(02): 177-188
DOI: 10.1055/s-0041-1725139
Review Article

Retention of Physical Gains in the Community Following Physical Training for Multiple Sclerosis: A Systematic Review and Implications

Victor W. Mark
1   Departments of Physical Medicine and Rehabilitation, Neurology, and Psychology, University of Alabama at Birmingham, Birmingham, Alabama
› Author Affiliations

Abstract

Multiple sclerosis (MS) is a progressive neurological illness whose typically young adult onset results in a nearly entire lifetime of worsening disability. But despite being an unrelenting neurodegenerative disease, numerous clinical trials over the past 40 years for MS have vigorously attempted to improve or at least stabilize declining physical function. Although the vast majority of the studies assessed training effects only within controlled laboratory or clinic settings, in recent years a growing interest has emerged to test whether newer therapies can instead benefit real-life activities in the community. Nonetheless, comparatively little attention has been paid to whether the training gains can be retained for meaningful periods. This review discusses the comparative success of various physical training methods to benefit within-community activities in MS, and whether the gains can be retained long afterward. This review will suggest future research directions toward establishing efficacious treatments that can allow persons with MS to reclaim their physical abilities and maximize functionality for meaningful periods.



Publication History

Article published online:
09 March 2021

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Hirtz D, Thurman DJ, Gwinn-Hardy K, Mohamed M, Chaudhuri AR, Zalutsky R. How common are the “common” neurologic disorders?. Neurology 2007; 68 (05) 326-337
  • 2 Peterson JW, Trapp BD. Neuropathobiology of multiple sclerosis. Neurol Clin 2005; 23 (01) 107-129 , vi–vii
  • 3 Browne P, Chandraratna D, Angood C. et al. Atlas of Multiple Sclerosis 2013: a growing global problem with widespread inequity. Neurology 2014; 83 (11) 1022-1024
  • 4 Wootla B, Watzlawik JO, Stavropoulos N. et al. Recent advances in monoclonal antibody therapies for multiple sclerosis. Expert Opin Biol Ther 2016; 16 (06) 827-839
  • 5 Wingerchuk DM, Carter JL. Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies. Mayo Clin Proc 2014; 89 (02) 225-240
  • 6 Kraft GH. Rehabilitation still the only way to improve function in multiple sclerosis. Lancet 1999; 354 (9195): 2016-2017
  • 7 Ploughman M. A new era of multiple sclerosis rehabilitation: lessons from stroke. Lancet Neurol 2017; 16 (10) 768-769
  • 8 Cree BAC, Hollenbach JA, Bove R. et al; University of California, San Francisco MS-EPIC Team. Silent progression in disease activity-free relapsing multiple sclerosis. Ann Neurol 2019; 85 (05) 653-666
  • 9 Finlayson M, Plow M, Cho C. Use of physical therapy services among middle-aged and older adults with multiple sclerosis. Phys Ther 2010; 90 (11) 1607-1618
  • 10 Rietberg MB, Brooks D, Uitdehaag BMJ, Kwakkel G. Exercise therapy for multiple sclerosis. Cochrane Database Syst Rev 2005; (01) CD003980
  • 11 Frau J, Coghe G, Lorefice L. et al. Attitude towards physical activity in patients with multiple sclerosis: a cohort study. Neurol Sci 2015; 36 (06) 889-893
  • 12 Yadav V, Shinto L, Morris C, Senders A, Baldauf-Wagner S, Bourdette D. Use and self-reported benefit of complementary and alternative medicine among multiple sclerosis patients. Int J MS Care 1999; 8: 5-10
  • 13 Maker-Clark G, Patel S. Integrative therapies for multiple sclerosis. Dis Mon 2013; 59 (08) 290-301
  • 14 Claflin SB, van der Mei IAF, Taylor BV. Complementary and alternative treatments of multiple sclerosis: a review of the evidence from 2001 to 2016. J Neurol Neurosurg Psychiatry 2018; 89 (01) 34-41
  • 15 Halabchi F, Alizadeh Z, Sahraian MA, Abolhasani M. Exercise prescription for patients with multiple sclerosis; potential benefits and practical recommendations. BMC Neurol 2017; 17 (01) 185
  • 16 Baird JF, Sandroff BM, Motl RW. Therapies for mobility disability in persons with multiple sclerosis. Expert Rev Neurother 2018; 18 (06) 493-502
  • 17 Pilutti LA, Hicks AL. Rehabilitation of ambulatory limitations. Phys Med Rehabil Clin N Am 2013; 24 (02) 277-290
  • 18 Latimer-Cheung AE, Pilutti LA, Hicks AL. et al. Effects of exercise training on fitness, mobility, fatigue, and health-related quality of life among adults with multiple sclerosis: a systematic review to inform guideline development. Arch Phys Med Rehabil 2013; 94 (09) 1800.e3-1828.e3
  • 19 Sasaki JE, Motl RW, Cutter G, Marrie RA, Tyry T, Salter A. National estimates of self-reported sitting time in adults with multiple sclerosis. Mult Scler J Exp Transl Clin 2018; 4 (01) 2055217318754368
  • 20 Pike J, Jones E, Rajagopalan K, Piercy J, Anderson P. Social and economic burden of walking and mobility problems in multiple sclerosis. BMC Neurol 2012; 12: 94
  • 21 Larocca NG. Impact of walking impairment in multiple sclerosis: perspectives of patients and care partners. Patient 2011; 4 (03) 189-201
  • 22 Heesen C, Böhm J, Reich C, Kasper J, Goebel M, Gold SM. Patient perception of bodily functions in multiple sclerosis: gait and visual function are the most valuable. Mult Scler 2008; 14 (07) 988-991
  • 23 Scheinberg L, Holland N, Larocca N, Laitin P, Bennett A, Hall H. Multiple sclerosis; earning a living. N Y State J Med 1980; 80 (09) 1395-1400
  • 24 Einarsson U, Gottberg K, Fredrikson S, von Koch L, Holmqvist LW. Activities of daily living and social activities in people with multiple sclerosis in Stockholm County. Clin Rehabil 2006; 20 (06) 543-551
  • 25 Lee IM, Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT. Lancet Physical Activity Series Working Group. Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet 2012; 380 (9838): 219-229
  • 26 Ding D, Lawson KD, Kolbe-Alexander TL. et al; Lancet Physical Activity Series 2 Executive Committee. The economic burden of physical inactivity: a global analysis of major non-communicable diseases. Lancet 2016; 388 (10051): 1311-1324
  • 27 Morris KS, McAuley E, Motl RW. Self-efficacy and environmental correlates of physical activity among older women and women with multiple sclerosis. Health Educ Res 2008; 23 (04) 744-752
  • 28 Shnek ZM, Foley FW, LaRocca NG. et al. Helplessness, self-efficacy, cognitive distortions, and depression in multiple sclerosis and spinal cord injury. Ann Behav Med 1997; 19 (03) 287-294
  • 29 Mertin J. Rehabilitation in multiple sclerosis. Ann Neurol 1994; 36 (Suppl): S130-S133
  • 30 Noseworthy JH. Clinical scoring methods for multiple sclerosis. Ann Neurol 1994; 36 (Suppl): S80-S85
  • 31 Freeman JA, Langdon DW, Hobart JC, Thompson AJ. Inpatient rehabilitation in multiple sclerosis: do the benefits carry over into the community?. Neurology 1999; 52 (01) 50-56
  • 32 Petajan JH, White AT. Recommendations for physical activity in patients with multiple sclerosis. Sports Med 1999; 27 (03) 179-191
  • 33 Dalgas U, Stenager E, Ingemann-Hansen T. Multiple sclerosis and physical exercise: recommendations for the application of resistance-, endurance- and combined training. Mult Scler 2008; 14 (01) 35-53
  • 34 Bever CT, Judge SI. Sustained-release fampridine for multiple sclerosis. Expert Opin Investig Drugs 2009; 18 (07) 1013-1024
  • 35 Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33 (11) 1444-1452
  • 36 Block VJ, Lizée A, Crabtree-Hartman E. et al. Continuous daily assessment of multiple sclerosis disability using remote step count monitoring. J Neurol 2017; 264 (02) 316-326
  • 37 Engelhard MM, Patek SD, Lach JC, Goldman MD. Real-world walking in multiple sclerosis: Separating capacity from behavior. Gait Posture 2018; 59: 211-216
  • 38 Plummer P, Anderson J, Stewart A. On the importance of gait speed: perspectives from people with multiple sclerosis and neurologic physical therapists. Int J MS Care 2019; 21 (Suppl. 01) 97
  • 39 Nowinski CJ, Miller DM, Cella D. Evolution of patient-reported outcomes and their role in multiple sclerosis clinical trials. Neurotherapeutics 2017; 14 (04) 934-944
  • 40 Sims RV, McGwin Jr G, Pulley LV, Roseman JM. Mobility impairments in crash-involved older drivers. J Aging Health 2001; 13 (03) 430-438
  • 41 Cohen J. Statistical Power Analysis for the Behavioral Sciences. Hillsdale NJ: Lawrence Erlbaum; 1988
  • 42 Hobart JC, Riazi A, Lamping DL, Fitzpatrick R, Thompson AJ. Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12). Neurology 2003; 60 (01) 31-36
  • 43 Freeman JA, Gear M, Pauli A. et al. The effect of core stability training on balance and mobility in ambulant individuals with multiple sclerosis: a multi-centre series of single case studies. Mult Scler 2010; 16 (11) 1377-1384
  • 44 Feys P, Tytgat K, Gijbels D, De Groote L, Baert I, Van Asch P. Effects of an 1-day education program on physical functioning, activity and quality of life in community living persons with multiple sclerosis. NeuroRehabilitation 2013; 33 (03) 439-448
  • 45 Downing A, Van Ryn D, Fecko A. et al. Effect of a 2-week trial of functional electrical stimulation on gait function and quality of life in people with multiple sclerosis. Int J MS Care 2014; 16 (03) 146-152
  • 46 Mandelbaum R, Triche EW, Fasoli SE, Lo A. The effects of salsa dance on gait and balance in multiple sclerosis. Neurology 2014; 82: P3.053
  • 47 Mandelbaum R, Triche EW, Fasoli SE, Lo AC. A pilot study: examining the effects and tolerability of structured dance intervention for individuals with multiple sclerosis. Disabil Rehabil 2016; 38 (03) 218-222
  • 48 Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med J 1965; 14 (02) 61-65
  • 49 Gresham GE, Phillips TF, Labi MLC. ADL status in stroke: relative merits of three standard indexes. Arch Phys Med Rehabil 1980; 61 (08) 355-358
  • 50 Roy CW, Togneri J, Hay E, Pentland B. An inter-rater reliability study of the Barthel Index. Int J Rehabil Res 1988; 11: 67-70
  • 51 Taub E, Miller NE, Novack TA. et al. Technique to improve chronic motor deficit after stroke. Arch Phys Med Rehabil 1993; 74 (04) 347-354
  • 52 Craig CL, Marshall AL, Sjöström M. et al. International Physical Activity Questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003; 35 (08) 1381-1395
  • 53 Godin G, Shephard RJ. Godin Leisure-Time Exercise Questionnaire. Med Sci Sports Exerc 1997; 29 (Suppl. 06) S36-S38
  • 54 Baecke JAH, Burema J, Frijters JER. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982; 36 (05) 936-942
  • 55 Straudi S, Martinuzzi C, Pavarelli C. et al. A task-oriented circuit training in multiple sclerosis: a feasibility study. BMC Neurol 2014; 14: 124
  • 56 Kjølhede T, Vissing K, de Place L. et al. Neuromuscular adaptations to long-term progressive resistance training translates to improved functional capacity for people with multiple sclerosis and is maintained at follow-up. Mult Scler 2015; 21 (05) 599-611
  • 57 Fox EE, Hough AD, Creanor S, Gear M, Freeman JA. Effects of Pilates-based core stability training in ambulant people with multiple sclerosis: multicenter, assessor-blinded, randomized controlled trial. Phys Ther 2016; 96 (08) 1170-1178
  • 58 Hayes S, Uszynski MK, Motl RW. et al. Randomised controlled pilot trial of an exercise plus behaviour change intervention in people with multiple sclerosis: the Step it Up study. BMJ Open 2017; 7 (10) e016336
  • 59 Tavazzi E, Bergsland N, Cattaneo D. et al. Effects of motor rehabilitation on mobility and brain plasticity in multiple sclerosis: a structural and functional MRI study. J Neurol 2018; 265 (06) 1393-1401
  • 60 Martini DN, Zeeboer E, Hildebrand A, Fling BW, Hugos CL, Cameron MH. ADSTEP: preliminary investigation of a multicomponent walking aid program in people with multiple sclerosis. Arch Phys Med Rehabil 2018; 99 (10) 2050-2058
  • 61 Dlugonski D, Motl RW, Mohr DC, Sandroff BM. Internet-delivered behavioral intervention to increase physical activity in persons with multiple sclerosis: sustainability and secondary outcomes. Psychol Health Med 2012; 17 (06) 636-651
  • 62 Carter A, Daley A, Humphreys L. et al. Pragmatic intervention for increasing self-directed exercise behaviour and improving important health outcomes in people with multiple sclerosis: a randomised controlled trial. Mult Scler 2014; 20 (08) 1112-1122
  • 63 Vaney C, Gattlen B, Lugon-Moulin V. et al. Robotic-assisted step training (lokomat) not superior to equal intensity of over-ground rehabilitation in patients with multiple sclerosis. Neurorehabil Neural Repair 2012; 26 (03) 212-221
  • 64 Craig J, Young CA, Ennis M, Baker G, Boggild M. A randomised controlled trial comparing rehabilitation against standard therapy in multiple sclerosis patients receiving intravenous steroid treatment. J Neurol Neurosurg Psychiatry 2003; 74 (09) 1225-1230
  • 65 Collett J, Dawes H, Meaney A. et al. Exercise for multiple sclerosis: a single-blind randomized trial comparing three exercise intensities. Mult Scler 2011; 17 (05) 594-603
  • 66 Mark VW, Taub E, Bashir K. et al. Constraint-induced movement therapy can improve hemiparetic progressive multiple sclerosis. Preliminary findings. Mult Scler 2008; 14 (07) 992-994
  • 67 Mark VW, Taub E, Uswatte G. et al. Phase II randomized controlled trial of constraint-induced movement therapy in multiple sclerosis. Part 1: effects on real-world function. Neurorehabil Neural Repair 2018; 32 (03) 223-232
  • 68 Mehta L, McNeill M, Hobart J. et al. Identifying an important change estimate for the Multiple Sclerosis Walking Scale-12 (MSWS-12v1) for interpreting clinical trial results. Mult Scler J Exp Transl Clin 2015; 1: 2055217315596993
  • 69 Hsieh YW, Wang CH, Wu SC, Chen PC, Sheu CF, Hsieh CL. Establishing the minimal clinically important difference of the Barthel Index in stroke patients. Neurorehabil Neural Repair 2007; 21 (03) 233-238
  • 70 Lang CE, Edwards DF, Birkenmeier RL, Dromerick AW. Estimating minimal clinically important differences of upper-extremity measures early after stroke. Arch Phys Med Rehabil 2008; 89 (09) 1693-1700
  • 71 Ingram G, Colley E, Ben-Shlomo Y. et al. Validity of patient-derived disability and clinical data in multiple sclerosis. Mult Scler 2010; 16 (04) 472-479
  • 72 Mark VW, Taub E, Cutter GR. et al. The measurement of upper extremity learned nonuse in multiple sclerosis. Int J MS Care 2010; 12 (Suppl. 01) 49
  • 73 Taub E, Uswatte G, Pidikiti R. Constraint-induced movement therapy: a new family of techniques with broad application to physical rehabilitation--a clinical review. J Rehabil Res Dev 1999; 36 (03) 237-251
  • 74 Collins ME, Mark VW, Taub E, Uswatte G, McKay S, D'Andrea Lee R. Validating a community-based measure of leg use for multiple sclerosis. Int J MS Care 2014; 16: 82-83
  • 75 Bandura A. Health promotion by social cognitive means. Health Educ Behav 2004; 31 (02) 143-164
  • 76 Taub E. Somatosensory deafferentation research with monkeys: implications for rehabilitation medicine. In: Ince LP. ed. Behavioral Psychology in Rehabilitation Medicine: Clinical Applications. Baltimore, MD: Williams and Wilkins, 1980; 371-401
  • 77 Wolf SL, Winstein CJ, Miller JP. et al; EXCITE Investigators. Effect of constraint-induced movement therapy on upper extremity function 3 to 9 months after stroke: the EXCITE randomized clinical trial. JAMA 2006; 296 (17) 2095-2104
  • 78 Shaw SE, Morris DM, Uswatte G, McKay S, Meythaler JM, Taub E. Constraint-induced movement therapy for recovery of upper-limb function following traumatic brain injury. J Rehabil Res Dev 2005; 42 (06) 769-778
  • 79 Taub E, Ramey SL, DeLuca S, Echols K. Efficacy of constraint-induced movement therapy for children with cerebral palsy with asymmetric motor impairment. Pediatrics 2004; 113 (02) 305-312
  • 80 Morris DM, Taub E, Mark VW. Constraint-induced movement therapy: characterizing the intervention protocol. Eura Medicophys 2006; 42 (03) 257-268
  • 81 Uswatte G, Taub E, Morris D, Light K, Thompson PA. The Motor Activity Log-28: assessing daily use of the hemiparetic arm after stroke. Neurology 2006; 67 (07) 1189-1194
  • 82 Barghi A, Allendorfer JB, Taub E. et al. Phase II randomized controlled trial of constraint-induced movement therapy in multiple sclerosis. Part 2: effect on white matter integrity. Neurorehabil Neural Repair 2018; 32 (03) 233-241
  • 83 Prosperini L, Piattella MC, Giannì C, Pantano P. Functional and structural brain plasticity enhanced by motor and cognitive rehabilitation in multiple sclerosis. Neural Plast 2015; 2015: 481574
  • 84 Grussu F, Schneider T, Tur C. et al. Neurite dispersion: a new marker of multiple sclerosis spinal cord pathology?. Ann Clin Transl Neurol 2017; 4 (09) 663-679
  • 85 Spanò B, Giulietti G, Pisani V. et al. Disruption of neurite morphology parallels MS progression. Neurol Neuroimmunol Neuroinflamm 2018; 5 (06) e502
  • 86 Alarcón F, Zijlmans JCM, Dueñas G, Cevallos N. Post-stroke movement disorders: report of 56 patients. J Neurol Neurosurg Psychiatry 2004; 75 (11) 1568-1574
  • 87 Jespersen SN, Bjarkam CR, Nyengaard JR. et al. Neurite density from magnetic resonance diffusion measurements at ultrahigh field: comparison with light microscopy and electron microscopy. Neuroimage 2010; 49 (01) 205-216
  • 88 Mark VW, Taub E, Uswatte G. et al. Constraint-induced movement therapy for the lower extremities in multiple sclerosis: case series with 4-year follow-up. Arch Phys Med Rehabil 2013; 94 (04) 753-760
  • 89 Mark VW, Taub E, Uswatte G, Morris DM, Bowman MH, McKay S. Unprecedented long-term retention of motor community gains following Constraint-Induced Movement therapy for MS. Int J MS Care 2019; 21 (Suppl. 01) 90
  • 90 Taub E, Uswatte G, King DK, Morris D, Crago JE, Chatterjee A. A placebo-controlled trial of constraint-induced movement therapy for upper extremity after stroke. Stroke 2006; 37 (04) 1045-1049
  • 91 Taub E, Uswatte G, Mark VW. et al. Method for enhancing real-world use of a more affected arm in chronic stroke: transfer package of constraint-induced movement therapy. Stroke 2013; 44 (05) 1383-1388
  • 92 Uswatte G, Taub E, Morris D, Barman J, Crago J. Contribution of the shaping and restraint components of Constraint-Induced Movement therapy to treatment outcome. NeuroRehabilitation 2006; 21 (02) 147-156
  • 93 Takebayashi T, Amano S, Hanada K. et al. A one-year follow-up after modified constraint-induced movement therapy for chronic stroke patients with paretic arm: a prospective case series study. Top Stroke Rehabil 2015; 22 (01) 18-25
  • 94 Martinková P, Freeman J, Drabinová A. et al. Physiotherapeutic interventions in multiple sclerosis across Europe: regions and other factors that matter. Mult Scler Relat Disord 2018; 22: 59-67
  • 95 Tur C, Moccia M, Barkhof F. et al. Assessing treatment outcomes in multiple sclerosis trials and in the clinical setting. Nat Rev Neurol 2018; 14 (02) 75-93
  • 96 Block VJ, Bove R, Zhao C. et al. Association of continuous assessment of step count by remote monitoring with disability progression among adults with multiple sclerosis. JAMA Netw Open 2019; 2 (03) e190570
  • 97 Nazareth TA, Rava AR, Polyakov JL. et al. Relapse prevalence, symptoms, and health care engagement: patient insights from the Multiple Sclerosis in America 2017 survey. Mult Scler Relat Disord 2018; 26: 219-234
  • 98 Blight AR. Treatment of walking impairment in multiple sclerosis with dalfampridine. Ther Adv Neurol Disorder 2011; 4 (02) 99-109
  • 99 Crayton H, Sidovar M, Wulf S, Guo A. Patient perspectives and experience with dalfampridine treatment in multiple sclerosis-related walking impairment: the step together program. Patient 2015; 8 (03) 283-291
  • 100 Zörner B, Filli L, Reuter K. et al. Prolonged-release fampridine in multiple sclerosis: Improved ambulation effected by changes in walking pattern. Mult Scler 2016; 22 (11) 1463-1475
  • 101 Sagawa Y, Watelain E, Moulin T, Decavel P. No effect of fampridine on real-life physical activity in people with multiple sclerosis. Ann Phys Rehabil Med 2018; 61 (02) 105-107
  • 102 Kjølhede T, Siemonsen S, Wenzel D. et al. Can resistance training impact MRI outcomes in relapsing-remitting multiple sclerosis?. Mult Scler 2018; 24 (10) 1356-1365
  • 103 Feys P, Moumdjian L, Van Halewyck F. et al. Effects of an individual 12-week community-located “start-to-run” program on physical capacity, walking, fatigue, cognitive function, brain volumes, and structures in persons with multiple sclerosis. Mult Scler 2019; 25 (01) 92-103
  • 104 Gauthier LV, Taub E, Perkins CE, Ortmann M, Mark VW, Uswatte G. Remodeling the brain: plastic structural brain changes produced by different motor therapies after stroke. Stroke 2008; 39 (05) 1520-1525
  • 105 Sterling C, Taub E, Davis D. et al. Structural neuroplastic change after constraint-induced movement therapy in children with cerebral palsy. Pediatrics 2013; 131 (05) e1664-e1669
  • 106 Filippi M, Rocca MA. MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system. J Neurol 2005; 252 (Suppl. 05) v16-v24